| human | Q5 |
| P269 | IdRef ID | 074008730 |
| P213 | ISNI | 0000000350761441 |
| P8189 | National Library of Israel J9U ID | 987007335764105171 |
| P496 | ORCID iD | 0000-0003-3039-8155 |
| P214 | VIAF ID | 233529176 |
| P734 | family name | Matthay | Q113291692 |
| Matthay | Q113291692 | ||
| Matthay | Q113291692 | ||
| P735 | given name | Michael | Q4927524 |
| Michael | Q4927524 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | male | Q6581097 |
| Q34022566 | 4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumonia |
| Q92511372 | A Multicenter Study of the Causes and Consequences of Optimistic Expectations About Prognosis by Surrogate Decision-Makers in ICUs |
| Q39528473 | A Simple and Robust Bedside Model for Mortality Risk in Pediatric Patients With Acute Respiratory Distress Syndrome. |
| Q27350371 | A computational approach to understand in vitro alveolar morphogenesis |
| Q42614874 | A framework and mechanistically focused, in silico method for enabling rational translational research |
| Q35127903 | A multicenter study of key stakeholders' perspectives on communicating with surrogates about prognosis in intensive care units |
| Q64231034 | A prospective investigation of interleukin-8 levels in pediatric acute respiratory failure and acute respiratory distress syndrome |
| Q90577644 | A psychometric study of the decisional conflict scale in surrogate decision makers |
| Q35582580 | A simple classification model for hospital mortality in patients with acute lung injury managed with lung protective ventilation |
| Q58604180 | AIMing Immunomodulation Therapy at Sepsis |
| Q33734288 | Accumulation of BDCA1⁺ dendritic cells in interstitial fibrotic lung diseases and Th2-high asthma |
| Q33213618 | Accuracy of physiologic dead space measurements in patients with acute respiratory distress syndrome using volumetric capnography: comparison with the metabolic monitor method. |
| Q42066672 | Activation of the alpha7 nAChR reduces acid-induced acute lung injury in mice and rats |
| Q28572134 | Activation of the heat shock response attenuates the interleukin 1β-mediated inhibition of the amiloride-sensitive alveolar epithelial ion transport |
| Q39715278 | Activation of the stress protein response inhibits the STAT1 signalling pathway and iNOS function in alveolar macrophages: role of Hsp90 and Hsp70. |
| Q35107236 | Active and passive cigarette smoking and acute lung injury after severe blunt trauma |
| Q50760424 | Activity of pulmonary edema fluid interleukin-8 bound to alpha(2)-macroglobulin in patients with acute lung injury. |
| Q33772426 | Acute Hypoxemic Respiratory Failure after Large-Volume Thoracentesis. Mechanisms of Pleural Fluid Formation and Reexpansion Pulmonary Edema |
| Q44766880 | Acute cardiopulmonary effects of a dual-endothelin receptor antagonist on oleic acid-induced pulmonary arterial hypertension in dogs. |
| Q45146601 | Acute cor pulmonale and the acute respiratory distress syndrome |
| Q45220177 | Acute effects of tidal volume strategy on hemodynamics, fluid balance, and sedation in acute lung injury |
| Q30423619 | Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes |
| Q26852173 | Acute lung failure |
| Q35896798 | Acute lung injury and acute respiratory distress syndrome in pregnancy |
| Q46666195 | Acute lung injury and the acute respiratory distress syndrome |
| Q36261456 | Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management |
| Q36505016 | Acute lung injury and the coagulation pathway: Potential role of gene polymorphisms in the protein C and fibrinolytic pathways |
| Q37394874 | Acute lung injury edema fluid decreases net fluid transport across human alveolar epithelial type II cells |
| Q35944590 | Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis |
| Q35097126 | Acute lung injury: epidemiology, pathogenesis, and treatment |
| Q94029681 | Acute respiratory distress syndrome |
| Q84599941 | Acute respiratory distress syndrome after surgery: can the risk be decreased? |
| Q61738531 | Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial |
| Q91704531 | Acute respiratory distress syndrome subphenotypes and therapy responsive traits among preclinical models: protocol for a systematic review and meta-analysis |
| Q90614239 | Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis |
| Q46166562 | Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? |
| Q46143854 | Advances and challenges in translating stem cell therapies for clinical diseases |
| Q37058721 | Advances in critical care for the nephrologist: acute lung injury/ARDS. |
| Q35574081 | Advancing donor management research: design and implementation of a large, randomized, placebo-controlled trial |
| Q33183912 | Aerosolized beta(2)-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure |
| Q46656727 | Aerosolized beta-adrenergic agonist therapy reduces pulmonary edema following lung surgery |
| Q37238006 | Age-, sex-, and race-based differences among patients enrolled versus not enrolled in acute lung injury clinical trials. |
| Q35751094 | Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema |
| Q48599917 | Airway epithelium, inflammation, and mechanisms of disease: A tribute to Carol B. Basbaum. |
| Q46307901 | Airway pressures and early barotrauma in patients with acute lung injury and acute respiratory distress syndrome |
| Q37327475 | Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung |
| Q34074353 | Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. |
| Q36741745 | Alterations in the proteome of pulmonary alveolar type II cells in the rat after hepatic ischemia-reperfusion |
| Q35850300 | Altered lymphatics in an ovine model of congenital heart disease with increased pulmonary blood flow |
| Q37740568 | Alveolar Fluid Clearance in Pathologically Relevant Conditions: In Vitro and In Vivo Models of Acute Respiratory Distress Syndrome |
| Q36866746 | Alveolar edema fluid clearance and acute lung injury |
| Q33875114 | Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis |
| Q36412280 | Alveolar epithelial ion and fluid transport: recent progress |
| Q36284863 | Alveolar epithelium: role in lung fluid balance and acute lung injury |
| Q35022236 | Alveolar fluid clearance in patients with ARDS: does it make a difference? |
| Q34316213 | Alveolar fluid clearance is faster in women with acute lung injury compared to men. |
| Q46077509 | Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury |
| Q84005909 | An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals |
| Q36450427 | Animal models of transfusion-related acute lung injury |
| Q80357916 | Anti-IL-8 autoantibody:IL-8 immune complexes suppress spontaneous apoptosis of neutrophils |
| Q37275471 | Anti-chemokine autoantibody:chemokine immune complexes activate endothelial cells via IgG receptors |
| Q35913061 | Anti-inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury |
| Q42013900 | Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. |
| Q38204194 | Applying metabolomics to uncover novel biology in ARDS. |
| Q52688796 | Assessing Preventable Harms in the Intensive Care Unit: Data From a Tertiary Care Academic Medical Institution. |
| Q42420202 | Assessing the quantity of pulmonary edema in critically ill children |
| Q59487334 | Assessment of industry data on pulmonary and immunosuppressive effects of IQOS |
| Q74812214 | Assessment of lungs rejected for transplantation and implications for donor selection |
| Q92802492 | Association of Elevated Plasma Interleukin-18 Level With Increased Mortality in a Clinical Trial of Statin Treatment for Acute Respiratory Distress Syndrome |
| Q36925835 | Association of common genetic variation in the protein C pathway genes with clinical outcomes in acute respiratory distress syndrome |
| Q83221910 | Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury |
| Q35629866 | Bench-to-bedside review: the role of activated protein C in maintaining endothelial tight junction function and its relationship to organ injury |
| Q24800694 | Bench-to-bedside review: the role of the alveolar epithelium in the resolution of pulmonary edema in acute lung injury |
| Q51197077 | Beta-2-agonist treatment as a potential therapy for acute inhalational lung injury. |
| Q47649796 | Beta-adrenergic agonist therapy as a potential treatment for acute lung injury |
| Q80794251 | Beta2 adrenergic agonist therapy may enhance alveolar epithelial repair in patients with acute lung injury |
| Q91680571 | Beyond Low Tidal Volume Ventilation: Treatment Adjuncts for Severe Respiratory Failure in Acute Respiratory Distress Syndrome |
| Q42574642 | Beyond fishing: the role of discovery proteomics in mechanistic lung research |
| Q35544777 | Biological markers of lung injury before and after the institution of positive pressure ventilation in patients with acute lung injury |
| Q42117783 | Biology and pathology of fibroproliferation following the acute respiratory distress syndrome |
| Q37858108 | Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury |
| Q35140572 | Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients |
| Q36749015 | Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury |
| Q33750995 | Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome |
| Q85888224 | Biomarkers to exclude the diagnosis of ventilator-associated pneumonia |
| Q36650277 | Blood product transfusions and clinical outcomes in pediatric patients with acute lung injury |
| Q35537071 | Body temperature and mortality in patients with acute respiratory distress syndrome |
| Q40313879 | Bone marrow-derived cells participate in stromal remodeling of the lung following acute bacterial pneumonia in mice. |
| Q30438007 | CD47 deficiency protects mice from lipopolysaccharide-induced acute lung injury and Escherichia coli pneumonia |
| Q36638238 | Calcium flux and endothelial dysfunction during acute lung injury: a STIMulating target for therapy. |
| Q45131576 | Can nicotine treat sepsis? |
| Q36157546 | Cathepsin L Helps to Defend Mice from Infection with Influenza A. |
| Q42539706 | Cecal ligation model of sepsis in mice: new insights |
| Q44250290 | Cell therapy for lung disease: a step forward |
| Q37186946 | Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012 |
| Q46135344 | Cell-based Therapy in Sepsis: A Step Closer |
| Q42951948 | Cell-based therapy for acute lung injury: are we there yet? |
| Q34925929 | Central line infections |
| Q46554070 | Challenges in predicting which patients will develop ARDS. |
| Q45973061 | Cigarette Smoke Exposure Worsens Endotoxin-Induced Lung Injury and Pulmonary Edema in Mice. |
| Q36533745 | Cigarette Smoke Exposure and the Acute Respiratory Distress Syndrome |
| Q52726398 | Cigarette smoke exposure worsens acute lung injury in antibiotic-treated bacterial pneumonia in mice. |
| Q42738488 | Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-1 in human lung fibroblasts |
| Q40807427 | Cigarette smokers have exaggerated alveolar barrier disruption in response to lipopolysaccharide inhalation. |
| Q84004495 | Clara cell protein CC16. A new lung epithelial biomarker for acute lung injury |
| Q35167870 | Claudin-4 levels are associated with intact alveolar fluid clearance in human lungs |
| Q47572031 | Clinical Acute Lung Injury and Acute Respiratory Distress Syndrome |
| Q36351190 | Clinical evidence of early acute lung injury often precedes the diagnosis of ALI. |
| Q42831509 | Clinical immunology: Culprits with evolutionary ties |
| Q51694625 | Clinical measurement of pulmonary edema. |
| Q34480278 | Clinical practice. Acute pulmonary edema |
| Q36633471 | Clinical review: Early treatment of acute lung injury--paradigm shift toward prevention and treatment prior to respiratory failure |
| Q26865095 | Clinical review: Thinking outside the box--an iconoclastic view of current practice |
| Q39386200 | Clinical significance of elevated B-type natriuretic peptide in patients with acute lung injury with or without right ventricular dilatation: an observational cohort study |
| Q30445416 | Clinical trial design--effect of prone positioning on clinical outcomes in infants and children with acute respiratory distress syndrome |
| Q38664603 | Clinical trials in acute respiratory distress syndrome: challenges and opportunities. |
| Q46508757 | Clinical, Radiographic, Physiologic, and Biologic Measurements to Facilitate Personalized Medicine for ARDS. |
| Q44969141 | Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury |
| Q90059399 | Clinically relevant model of pneumococcal pneumonia, ARDS, and nonpulmonary organ dysfunction in mice |
| Q92130116 | Clinician Recognition of the Acute Respiratory Distress Syndrome: Risk Factors for Under-Recognition and Trends Over Time |
| Q92746721 | Clinician-Family Communication About Patients' Values and Preferences in Intensive Care Units |
| Q35825888 | Coagulation-dependent mechanisms and asthma |
| Q92130381 | Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis |
| Q91954414 | Combined Mesenchymal Stromal Cell Therapy and ECMO in ARDS: A Controlled Experimental Study in Sheep |
| Q36813034 | Comparison of chest radiograph scoring to lung weight as a quantitative index of pulmonary edema in organ donors |
| Q37355912 | Comparison of thermodilution measured extravascular lung water with chest radiographic assessment of pulmonary oedema in patients with acute lung injury |
| Q37360375 | Comparison of two non-bronchoscopic methods for evaluating inflammation in patients with acute hypoxaemic respiratory failure. |
| Q42755615 | Con: corticosteroids are not indicated for treatment of acute lung injury from H1N1 viral pneumonia. |
| Q39020468 | Concise Review: Mesenchymal Stem (Stromal) Cells: Biology and Preclinical Evidence for Therapeutic Potential for Organ Dysfunction Following Trauma or Sepsis |
| Q35801052 | Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors |
| Q33701911 | Conditioned media from mesenchymal stromal cells restore sodium transport and preserve epithelial permeability in an in vitro model of acute alveolar injury. |
| Q46743901 | Congenital diaphragmatic hernia prevents absorption of distal air space fluid in late-gestation rat fetuses |
| Q47215498 | Contemporary Risk Factors and Outcomes of Transfusion-Associated Circulatory Overload |
| Q89771031 | Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop |
| Q42483608 | Contribution of CFTR to apical-basolateral fluid transport in cultured human alveolar epithelial type II cells |
| Q58842102 | Contributors |
| Q46986995 | Correction: HMGB1 Accelerates Alveolar Epithelial Repair via an IL-1β- and αvβ6 Integrin-dependent Activation of TGF-β1. |
| Q87716727 | Correspondence to: soliciting strategies for developing cell-based reference materials to advance mesenchymal stem/stromal cell research and clinical translation |
| Q64087907 | Could Decisions to Limit Treatment Contribute to Mortality Differences between Patients with Different Presepsis Trajectories? |
| Q34400957 | Critical care in AJRCCM 2004. |
| Q53079931 | Cystic fibrosis epithelial cell and bacterial binding. |
| Q45324457 | Cytokine Profiles of Severe Influenza Virus-Related Complications in Children |
| Q35561675 | Cytokine-mediated inflammation in acute lung injury |
| Q35952205 | Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions |
| Q42475865 | Decreased expression of both the alpha1- and alpha2-subunits of the Na-K-ATPase reduces maximal alveolar epithelial fluid clearance |
| Q35019165 | Decreased respiratory system compliance on the sixth day of mechanical ventilation is a predictor of death in patients with established acute lung injury. |
| Q88687025 | Derivation and validation of a two-biomarker panel for diagnosis of ARDS in patients with severe traumatic injuries |
| Q34756148 | Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome |
| Q92710154 | Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials |
| Q47986825 | Diagnostic utility of B-type natriuretic peptide in patients with acute dyspnea or pleural effusions |
| Q33210758 | Differential effects of sustained inflation recruitment maneuvers on alveolar epithelial and lung endothelial injury |
| Q38805519 | Differentiating pulmonary transfusion reactions using recipient and transfusion factors |
| Q46632727 | Direct visual instillation as a method for efficient delivery of fluid into the distal airspaces of anesthetized mice |
| Q43882357 | Distal air space epithelial fluid clearance in near-term rat fetuses is fast and requires endogenous catecholamines |
| Q35672843 | Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies |
| Q36621790 | Dysfunction of inflammation-resolving pathways is associated with exaggerated postoperative cognitive decline in a rat model of the metabolic syndrome. |
| Q91043806 | ECMO in severe acute respiratory distress syndrome |
| Q45074078 | ENaCs as Both Effectors and Regulators of MiRNAs in Lung Epithelial Development and Regeneration |
| Q90980637 | Early Plasma Matrix Metalloproteinase Profiles. A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome |
| Q37108944 | Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation*. |
| Q39653395 | Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation |
| Q36650420 | Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation |
| Q35593180 | Early elevations in B-type natriuretic peptide levels are associated with poor clinical outcomes in pediatric acute lung injury |
| Q58803298 | Effect of Rosuvastatin on Acute Kidney Injury in Sepsis-Associated Acute Respiratory Distress Syndrome |
| Q51648877 | Effect of continuous hemofiltration on hemodynamics, lung inflammation and pulmonary edema in a canine model of acute lung injury. |
| Q34049582 | Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial |
| Q40064650 | Effects of IV Acetaminophen on Core Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults: A Randomized Controlled Trial |
| Q58722229 | Effects of bone marrow-derived mesenchymal stromal cells on gene expression in human alveolar type II cells exposed to TNF-α, IL-1β, and IFN-γ |
| Q51644918 | Effects of recruitment maneuvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high positive end-expiratory pressure* |
| Q33595107 | Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury |
| Q90682949 | Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility |
| Q49610444 | Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction. |
| Q47934955 | Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury |
| Q37270915 | Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs |
| Q40498147 | Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury |
| Q36424706 | Elevated soluble thrombomodulin is associated with organ failure and mortality in children with acute respiratory distress syndrome (ARDS): a prospective observational cohort study |
| Q51655192 | Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. |
| Q38277249 | Endogenous and exogenous cell-based pathways for recovery from acute respiratory distress syndrome |
| Q46692394 | Endothelial Damage During Septic Shock: Significance and Implications for Future Therapies |
| Q52633061 | Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS. |
| Q34667474 | Enhancing the safety of critically ill patients by reducing urinary and central venous catheter-related infections |
| Q38679109 | Epithelial Sodium Channel ENaC is a Modifier of the Long Term Non-progressive Phenotype Associated with F508del CFTR Mutations |
| Q41075014 | Epithelial Sodium Channel-α Mediates the Protective Effect of the TNF-Derived TIP Peptide in Pneumolysin-Induced Endothelial Barrier Dysfunction |
| Q42352654 | Erratum to: Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction - a randomised placebo-controlled trial (KARE): study protocol. |
| Q46265661 | Erratum to: plasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome. |
| Q35449898 | Estimating dead-space fraction for secondary analyses of acute respiratory distress syndrome clinical trials |
| Q46699746 | Evidence against aquaporin-1-dependent CO2 permeability in lung and kidney |
| Q45997504 | Evidence of temporary airway epithelial repopulation and rare clonal formation by BM-derived cells following naphthalene injury in mice. |
| Q36910440 | Evolving practices in critical care and potential implications for management of acute kidney injury. |
| Q45971576 | Exosome-Based Therapy for Bronchopulmonary Dysplasia. |
| Q89589648 | Expansion of hedgehog disrupts mesenchymal identity and induces emphysema phenotype |
| Q46081480 | External validation of a biomarker and clinical prediction model for hospital mortality in acute respiratory distress syndrome |
| Q46034742 | Extracellular Vesicle Transfer from Mesenchymal Stromal Cells Modulates Macrophage Function in Acute Lung Injury. Basic Science and Clinical Implications. |
| Q89935370 | Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome |
| Q37394895 | Extracellular heat shock protein 72 is a marker of the stress protein response in acute lung injury |
| Q91202825 | Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome |
| Q24685217 | Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome |
| Q35016067 | Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid mediates protective effects through regulation of the ERK pathway |
| Q38901248 | Fifty Years of Research in ARDS. Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value. |
| Q42457845 | Fluid transport across cultured rat alveolar epithelial cells: a novel in vitro system |
| Q30479326 | Formation of cysts by alveolar type II cells in three-dimensional culture reveals a novel mechanism for epithelial morphogenesis |
| Q36772263 | From protective ventilation to super-protective ventilation for acute respiratory distress syndrome |
| Q42169101 | Functional identification of the alveolar edema reabsorption activity of murine tumor necrosis factor-alpha |
| Q35093997 | Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group |
| Q92851409 | Gender Differences in Authorship of Critical Care Literature |
| Q34147463 | Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major trauma |
| Q34420043 | Genomics and proteomics of lung disease: conference summary |
| Q40560514 | H(2)O(2) inhibits alveolar epithelial wound repair in vitro by induction of apoptosis |
| Q34734005 | HMGB1 accelerates alveolar epithelial repair via an IL-1β- and αvβ6 integrin-dependent activation of TGF-β1 |
| Q64111485 | Heterogeneity in sepsis: new biological evidence with clinical applications |
| Q27316615 | Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis |
| Q47714832 | High prevalence of pulmonary arterial thrombi in donor lungs rejected for transplantation. |
| Q42436549 | High tidal volume ventilation induces NOS2 and impairs cAMP- dependent air space fluid clearance |
| Q47328997 | Higher mini-BAL total protein concentration in early ARDS predicts faster resolution of lung injury measured by more ventilator-free days |
| Q33433019 | Higher pulmonary dead space may predict prolonged mechanical ventilation after cardiac surgery |
| Q37394891 | Higher urine desmosine levels are associated with mortality in patients with acute lung injury |
| Q35855126 | Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injury |
| Q47952677 | Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome |
| Q41637014 | Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A4. |
| Q41887427 | Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. |
| Q35994803 | Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes |
| Q36770476 | Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo. |
| Q61810010 | Human pulmonary endothelial cell permeability after exposure to LPS-stimulated leukocyte supernatants derived from patients with early sepsis |
| Q46023510 | Hydrostatic mechanisms may contribute to the pathogenesis of human re-expansion pulmonary edema. |
| Q37401041 | Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death |
| Q38070146 | Hyperoxic acute lung injury |
| Q28569687 | Hypoxia and beta 2-agonists regulate cell surface expression of the epithelial sodium channel in native alveolar epithelial cells |
| Q44176981 | Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo |
| Q36615154 | IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K-dependent mechanism |
| Q37277169 | IL1RL1 asthma risk variants regulate airway type 2 inflammation |
| Q58592172 | Identification of Acute Kidney Injury Sub-phenotypes with Differing Molecular Signatures and Response to Vasopressin Therapy |
| Q37378563 | Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure |
| Q90159441 | Identifying Clinical Research Priorities in Adult Pulmonary and Critical Care: NHLBI Working Group Report |
| Q92130130 | Impact of Bilateral Infiltrates on Inflammatory Biomarker Levels and Clinical Outcomes of Children With Oxygenation Defect |
| Q42738516 | Impact of low and high tidal volumes on the rat alveolar epithelial type II cell proteome |
| Q91608538 | Improved survival after lung transplantation for adults requiring preoperative invasive mechanical ventilation: A national cohort study |
| Q45244847 | In vitro and in vivo regulation of transepithelial lung alveolar sodium transport by serine proteases |
| Q38751954 | Incorporating Inflammation into Mortality Risk in Pediatric Acute Respiratory Distress Syndrome. |
| Q35672031 | Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS. |
| Q89507791 | Influence of Clinical Factors and Exclusion Criteria on Mortality in ARDS Observational Studies and Randomized Controlled Trials |
| Q34131746 | Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy |
| Q37029639 | Informed consent in research to improve the number and quality of deceased donor organs |
| Q41190745 | Inhalation therapies in acute respiratory distress syndrome. |
| Q39971820 | Inhaled activated protein C: a novel therapy for acute lung injury? |
| Q52667392 | Inhibiting Bruton's Tyrosine Kinase Rescues Mice from Lethal Influenza Induced Acute Lung Injury. |
| Q35942414 | Integrated control of lung fluid balance |
| Q83337295 | Integrating acute lung injury and regulation of alveolar fluid clearance |
| Q60936761 | Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults |
| Q41811902 | Integrin alphavbeta5 regulates lung vascular permeability and pulmonary endothelial barrier function |
| Q35584514 | Intensive care unit scoring systems outperform emergency department scoring systems for mortality prediction in critically ill patients: a prospective cohort study. |
| Q90869207 | Interleukin-1 Receptor Antagonist Is Associated With Pediatric Acute Respiratory Distress Syndrome and Worse Outcomes in Children With Acute Respiratory Failure |
| Q37335873 | Interleukin-1beta causes acute lung injury via alphavbeta5 and alphavbeta6 integrin-dependent mechanisms. |
| Q42475319 | Interleukin-1beta decreases expression of the epithelial sodium channel alpha-subunit in alveolar epithelial cells via a p38 MAPK-dependent signaling pathway |
| Q37393718 | Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity. |
| Q42826405 | Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice |
| Q46054181 | Intratracheal instillation of alveolar type II cells enhances recovery from acute lung injury in rats. |
| Q34863713 | Invited review: Active fluid clearance from the distal air spaces of the lung |
| Q92356374 | Is a Part Better than the Whole for Cell-based Therapy for Acute Respiratory Distress Syndrome? |
| Q34823885 | Is there a need for emerging drugs for the acute respiratory distress syndrome? |
| Q36246746 | Is there a role for beta-adrenoceptor agonists in the management of acute lung injury and the acute respiratory distress syndrome? |
| Q37597232 | Is there still a role for the lung injury score in the era of the Berlin definition ARDS? |
| Q28214201 | Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair |
| Q44024794 | Keratinocyte growth factor can enhance alveolar epithelial repair by nonmitogenic mechanisms |
| Q38774032 | Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial. |
| Q36751603 | Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction--a randomised placebo-controlled trial (KARE): study protocol. |
| Q57362929 | Keratinocyte growth factor promotes cell motility during alveolar epithelial repair in vitro |
| Q34480171 | Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury |
| Q46874437 | Key stakeholders' perceptions of the acceptability and usefulness of a tablet-based tool to improve communication and shared decision making in ICUs |
| Q33646134 | Laminin gamma2 fragments are increased in the circulation of patients with early phase acute lung injury |
| Q57021865 | Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study |
| Q42639998 | Leukotrienes in acute lung injury: a potential therapeutic target? |
| Q42516604 | Lidocaine induces a reversible decrease in alveolar epithelial fluid clearance in rats |
| Q34619626 | Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. |
| Q35032592 | Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury |
| Q40122514 | Local lung hypoxia determines epithelial fate decisions during alveolar regeneration. |
| Q36916053 | Long-Term Ozone Exposure Increases the Risk of Developing the Acute Respiratory Distress Syndrome. |
| Q75353822 | Look before you leap: how do intensivists improve care for critically ill patients? |
| Q77487133 | Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs |
| Q57102680 | Low to Moderate Air Pollutant Exposure and Acute Respiratory Distress Syndrome after Severe Trauma |
| Q45220170 | Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury |
| Q38727015 | Lung Injury Etiology and Other Factors Influencing the Relationship Between Dead-Space Fraction and Mortality in ARDS. |
| Q34998577 | Lung edema clearance: 20 years of progress: invited review: alveolar edema fluid clearance in the injured lung |
| Q80610732 | Lung epithelial cells induce endodermal differentiation in mouse mesenchymal bone marrow stem cells by paracrine mechanism |
| Q34711181 | Lung epithelial fluid transport and the resolution of pulmonary edema |
| Q90279284 | Lung inflammatory environments differentially alter mesenchymal stromal cell behavior |
| Q36020530 | Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis. |
| Q40134262 | MAPK pathway mediates EGR-1-HSP70-dependent cigarette smoke-induced chemokine production |
| Q44772511 | Malnutrition impairs alveolar fluid clearance in rat lungs |
| Q89484443 | Measurement of Protein Permeability and Fluid Transport of Human Alveolar Epithelial Type II Cells Under Pathological Conditions |
| Q46623275 | Measurement of extravascular lung water in patients with pulmonary edema |
| Q37406423 | Measurement of extravascular lung water using the single indicator method in patients: research and potential clinical value. |
| Q78430721 | Measuring microvascular blood flow in sepsis--a continuing challenge |
| Q45189362 | Measuring the quantity of pulmonary edema in clinical lung injury |
| Q34070629 | Mechanical ventilation in acute hypoxemic respiratory failure: a review of new strategies for the practicing hospitalist |
| Q35683691 | Mechanisms of alveolar protein clearance in the intact lung |
| Q47281982 | Mesenchymal Stem Cell Derived Extracellular Vesicles Attenuate Pulmonary Vascular Permeability and Lung Injury Induced by Hemorrhagic Shock and Trauma. |
| Q34979725 | Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial |
| Q46956115 | Mesenchymal stem (stromal) cells for treatment of acute respiratory distress syndrome - authors' reply |
| Q37899553 | Mesenchymal stem cells and acute lung injury |
| Q38073092 | Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing |
| Q83897220 | Mesenchymal stem cells and the stem cell niche: a new chapter |
| Q42176451 | Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia. |
| Q36634584 | Mesenchymal stem cells for acute lung injury: preclinical evidence |
| Q84924901 | Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia: delivering the secretome |
| Q38281388 | Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis |
| Q51755670 | Mesenchymal stromal (stem) cell therapy: an emerging immunomodulatory strategy for the adjunctive treatment of sepsis. |
| Q52560322 | Mesenchymal stromal cells and macrophages in sepsis: new insights. |
| Q41847811 | Mesenchymally "stemming" angiogenesis |
| Q58735023 | Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury |
| Q51696406 | Meta-analysis of acute lung injury and acute respiratory distress syndrome trials. |
| Q37534631 | Metabolomic derangements are associated with mortality in critically ill adult patients |
| Q51724119 | Microarray analysis indicates that pulmonary edema fluid from patients with acute lung injury mediates inflammation, mitogen gene expression, and fibroblast proliferation through bioactive interleukin-1. |
| Q41769822 | Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS. |
| Q112714059 | Molecular programs of fibrotic change in aging human lung |
| Q94480022 | Monitoring Research Blood Sampling in Critically Ill Patients: Avoiding Iatrogenic Anemia |
| Q36792255 | Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential |
| Q28588550 | NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice |
| Q38803924 | Negative-Pressure Pulmonary Edema |
| Q34695953 | Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury. |
| Q42691878 | Neutrophil sandwiches injure the microcirculation |
| Q34619641 | Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. |
| Q113756582 | New Insights into Clinical and Mechanistic Heterogeneity of the Acute Respiratory Distress Syndrome: Summary of the Aspen Lung Conference 2021 |
| Q40781698 | New Strategies for Effective Therapeutics in Critically Ill Patients. |
| Q36758874 | Nonventilatory treatments for acute lung injury and ARDS. |
| Q37680580 | Noradrenergic neurons regulate monocyte trafficking and mortality during gram-negative peritonitis in mice |
| Q36494857 | Novel aspects of urokinase function in the injured lung: role of α2-macroglobulin |
| Q42589086 | Novel molecular strategy to prevent pulmonary edema |
| Q35855295 | Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation |
| Q37619561 | One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome |
| Q46794889 | Overnight Extubation in Patients With Mechanical Ventilation: Is It Harmful? |
| Q35604061 | Pancreatitis-associated acute lung injury: new insights |
| Q91794526 | Pathogenesis of Acute Respiratory Distress Syndrome |
| Q36312498 | Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials |
| Q36682509 | Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies |
| Q37770036 | Pathophysiology of transfusion-related acute lung injury |
| Q89970829 | Patterns and Trends in Advance Care Planning Among Older Adults Who Received Intensive Care at the End of Life |
| Q47874594 | Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality |
| Q90753045 | Peripheral blood leukocyte telomere length is associated with survival of sepsis patients |
| Q82796853 | Perspectives, translational research, and letters to the editor |
| Q36467694 | Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome |
| Q102146984 | Phenotypes and personalized medicine in the acute respiratory distress syndrome |
| Q91423853 | Physiologic Analysis and Clinical Performance of the Ventilatory Ratio in Acute Respiratory Distress Syndrome |
| Q37393712 | Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs |
| Q41714773 | Plasma Concentrations of Soluble Suppression of Tumorigenicity-2 and Interleukin-6 Are Predictive of Successful Liberation From Mechanical Ventilation in Patients With the Acute Respiratory Distress Syndrome |
| Q57806601 | Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis |
| Q34275412 | Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance |
| Q33891477 | Plasma angiopoietin-2 outperforms other markers of endothelial injury in prognosticating pediatric ARDS mortality. |
| Q36917451 | Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients |
| Q33994636 | Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis |
| Q35946158 | Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shock |
| Q46618413 | Plasma protein C levels in patients with acute lung injury: prognostic significance |
| Q37340579 | Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation |
| Q93121591 | Plasma sRAGE Acts as a Genetically Regulated Causal Intermediate in Sepsis-associated Acute Respiratory Distress Syndrome |
| Q56888393 | Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data |
| Q91819776 | Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study |
| Q30360456 | Plasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome. |
| Q93122568 | Plasma total fibroblast growth factor 23 levels are associated with acute kidney injury and mortality in children with acute respiratory distress syndrome |
| Q90058442 | Plasmin improves oedematous blood-gas barrier by cleaving epithelial sodium channels |
| Q33386526 | Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury |
| Q44187536 | Pleural surface fluorescence measurement of Na+ and Cl- transport across the air space-capillary barrier |
| Q30386697 | Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. |
| Q39499954 | Poor Adherence to Lung-Protective Mechanical Ventilation in Pediatric Acute Respiratory Distress Syndrome. |
| Q91177727 | Positive Cumulative Fluid Balance Is Associated With Mortality in Pediatric Acute Respiratory Distress Syndrome in the Setting of Acute Kidney Injury |
| Q41824236 | Positive fluid balance is associated with higher mortality and prolonged mechanical ventilation in pediatric patients with acute lung injury |
| Q64984474 | Possible hepatotoxicity of IQOS. |
| Q36782624 | Postobstructive pulmonary edema: a case for hydrostatic mechanisms |
| Q89714844 | Potential Value of Biomarker Signatures in Sepsis and Acute Respiratory Distress Syndrome in Children and Adults |
| Q37582394 | Potential application of mesenchymal stem cells in acute lung injury |
| Q92704102 | Precision medicine for cell therapy in acute respiratory distress syndrome - Authors' reply |
| Q35801043 | Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. |
| Q30371072 | Prevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome. |
| Q31135164 | Prevention of ventilator-associated pneumonia: an evidence-based systematic review |
| Q42712136 | Priming with endotoxin increases acute lung injury in mice by enhancing the severity of lung endothelial injury |
| Q46084253 | Profiling of ARDS pulmonary edema fluid identifies a metabolically distinct subset. |
| Q30409730 | Prognostic and diagnostic value of plasma soluble suppression of tumorigenicity-2 concentrations in acute respiratory distress syndrome |
| Q33512670 | Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury |
| Q41904923 | Prognostic value of pulmonary dead space in patients with the acute respiratory distress syndrome |
| Q46040142 | Prognostic value of surfactant proteins A and D in patients with acute lung injury. |
| Q46684689 | Prognostic value of the pulmonary dead-space fraction during the first 6 days of acute respiratory distress syndrome. |
| Q84044691 | Progress in modelling acute lung injury in a pre-clinical mouse model |
| Q48030085 | Proinflammatory activity of anti-IL-8 autoantibody:IL-8 complexes in alveolar edema fluid from patients with acute lung injury |
| Q91387270 | Proliferative regulation of alveolar epithelial type 2 progenitor cells by human Scnn1d gene |
| Q40595354 | Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha |
| Q58574495 | Prospective Assessment of the Feasibility of a Trial of Low Tidal Volume Ventilation for Patients with Acute Respiratory Failure |
| Q34823967 | Prospective study on the clinical course and outcomes in transfusion-related acute lung injury* |
| Q37462187 | Prostaglandin E2 mediates IL-1beta-related fibroblast mitogenic effects in acute lung injury through differential utilization of prostanoid receptors. |
| Q46253083 | Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms |
| Q33899059 | Protective effect of Growth Hormone-Releasing Hormone agonist in bacterial toxin-induced pulmonary barrier dysfunction |
| Q46801130 | Protective effect of endogenous beta-adrenergic tone on lung fluid balance in acute bacterial pneumonia in mice. |
| Q37494702 | Protective mechanisms of activated protein C in severe inflammatory disorders. |
| Q40646976 | Protein C and thrombomodulin in human acute lung injury |
| Q39781143 | Protein C as a surrogate end-point for clinical trials of sepsis |
| Q36369969 | Protein kinase C-α and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability |
| Q79306253 | Protein permeability in lung injury: now in real time again? |
| Q37273851 | Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells |
| Q35126550 | Proteolytic regulation of epithelial sodium channels by urokinase plasminogen activator: cutting edge and cleavage sites |
| Q34784921 | Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells |
| Q33197095 | Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. |
| Q35798681 | Proteomics: current techniques and potential applications to lung disease |
| Q37114012 | Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: a randomized clinical trial |
| Q92355718 | Pulmonary Dead Space Monitoring: Identifying Subjects With ARDS at Risk of Developing Right Ventricular Dysfunction |
| Q36645125 | Pulmonary artery catheter and fluid management in acute lung injury and the acute respiratory distress syndrome |
| Q80584715 | Pulmonary barriers to pneumonia and sepsis |
| Q46033769 | Pulmonary dead space fraction and pulmonary artery systolic pressure as early predictors of clinical outcome in acute lung injury. |
| Q33183631 | Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome |
| Q44591500 | Pulmonary edema fluid antioxidants are depressed in acute lung injury |
| Q40592062 | Pulmonary edema fluid from patients with early lung injury stimulates fibroblast proliferation through IL-1 beta-induced IL-6 expression |
| Q58804459 | Pulmonary mechanics and gas exchange characteristics in uncommon etiologies of acute respiratory distress syndrome |
| Q34556933 | Pulmonary toxicity of e-cigarettes |
| Q43225998 | Quantifying the severity of acute lung injury using dead-space ventilation: should the lung injury score be updated? |
| Q41494263 | Quantifying unintended exposure to high tidal volumes from breath stacking dyssynchrony in ARDS: the BREATHE criteria |
| Q40084486 | Rac1 is required for reorientation of polarity and lumen formation through a PI 3-kinase-dependent pathway. |
| Q30437457 | Racial and ethnic disparities in mortality from acute lung injury |
| Q44663643 | Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome |
| Q36889970 | Randomized clinical trial of activated protein C for the treatment of acute lung injury |
| Q30425088 | Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury |
| Q33564598 | Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients. |
| Q33358793 | Reasons for nonenrollment in a clinical trial of acute lung injury |
| Q36143001 | Recent advances in mechanical ventilation |
| Q37227161 | Recent trends in acute lung injury mortality: 1996-2005. |
| Q37264745 | Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury |
| Q28566123 | Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury |
| Q35598121 | Recipient clinical risk factors predominate in possible transfusion-related acute lung injury |
| Q47216108 | Rectal and Bladder Temperatures vs Forehead Core Temperatures Measured With SpotOn Monitoring System. |
| Q33994671 | Regulated gene expression in cultured type II cells of adult human lung |
| Q38080559 | Regulation and repair of the alveolar-capillary barrier in acute lung injury |
| Q45992305 | Reperfusion pulmonary edema in children with tetralogy of Fallot, pulmonary atresia, and major aortopulmonary collateral arteries undergoing unifocalization procedures: A pilot study examining potential pathophysiologic mechanisms and clinical signi |
| Q46110506 | Reply to "Letter to the Editor: Pulmonary toxicity of electronic cigarettes: more doubts than certainties". |
| Q42644365 | Reply: idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach |
| Q33880932 | Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury. |
| Q46018266 | Resolution of Alveolar Edema in Acute Respiratory Distress Syndrome. Physiology and Biology. |
| Q33901613 | Resolution of pulmonary edema. Thirty years of progress |
| Q36839917 | Risk factors and outcomes in transfusion-associated circulatory overload |
| Q41920030 | Role of CFTR expressed by neutrophils in modulating acute lung inflammation and injury in mice |
| Q34974341 | Role of protease activated receptor 2 in experimental acute lung injury and lung fibrosis. |
| Q34559446 | Rosuvastatin for sepsis-associated acute respiratory distress syndrome |
| Q47703729 | Saving lives with high-flow nasal oxygen |
| Q24794627 | Science review: mechanisms of ventilator-induced injury |
| Q89142800 | Secondary peritonitis: principles of diagnosis and intervention |
| Q43780610 | Sedation protocol for critically ill pediatric patients--reply |
| Q44180865 | Selected contribution: mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung |
| Q83820389 | Sepsis and stretch: synergistic effects on alveolar epithelial cell death? |
| Q26746260 | Sepsis: pathophysiology and clinical management |
| Q39806286 | Serotonin decreases alveolar epithelial fluid transport via a direct inhibition of the epithelial sodium channel. |
| Q89107370 | Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS |
| Q40191513 | Signals of vagal circuits engaging with AKT1 in α7 nAChR+CD11b+ cells lessen E. coli and LPS-induced acute inflammatory injury |
| Q47333615 | Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury |
| Q34201274 | Silencing Bruton's tyrosine kinase in alveolar neutrophils protects mice from LPS/immune complex-induced acute lung injury |
| Q30495223 | Simulation of lung alveolar epithelial wound healing in vitro |
| Q37225099 | Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers |
| Q34482295 | Single-nucleotide polymorphisms in the β-adrenergic receptor genes are associated with lung allograft utilization |
| Q38337376 | Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock |
| Q33356631 | Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury |
| Q42787759 | Standards and recommendations for quantitative assessment of lung structure in research |
| Q36916458 | Stem cells in sepsis and acute lung injury. |
| Q37394870 | Stimulation of alveolar epithelial fluid clearance in human lungs by exogenous epinephrine |
| Q36003443 | Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. |
| Q30826105 | Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials |
| Q37147088 | Sugar administration is an effective adjunctive therapy in the treatment of Pseudomonas aeruginosa pneumonia |
| Q91808031 | Surfactant Protein D is Associated with Severe Pediatric Acute Respiratory Distress Syndrome, Prolonged Ventilation, and Death in Children with Acute Respiratory Failure |
| Q81304809 | Surfactant treatment of aspiration-induced lung injury in children |
| Q37519586 | TGF-β and lung fluid balance in ARDS |
| Q46844038 | TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK. |
| Q44492159 | The Berlin definition of ARDS versus pathological evidence of diffuse alveolar damage |
| Q58612533 | The Continued Need for Clinical Trials in Deceased Organ Donor Management |
| Q46523217 | The Role of Protein C in Sepsis |
| Q48111270 | The TLR4-PAR1 Axis Regulates Bone Marrow Mesenchymal Stromal Cell Survival and Therapeutic Capacity in Experimental Bacterial Pneumonia. |
| Q84693193 | The acute respiratory distress syndrome |
| Q39993880 | The acute respiratory distress syndrome following isolated severe traumatic brain injury |
| Q38846407 | The acute respiratory distress syndrome in 2013. |
| Q35025114 | The acute respiratory distress syndrome: pathogenesis and treatment |
| Q44183959 | The adenosine 2A receptor agonist GW328267C improves lung function after acute lung injury in rats. |
| Q36225788 | The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor |
| Q35929937 | The association between a Darc gene polymorphism and clinical outcomes in African American patients with acute lung injury |
| Q30370224 | The association between physiologic dead-space fraction and mortality in subjects with ARDS enrolled in a prospective multi-center clinical trial |
| Q92436346 | The authors reply |
| Q94006080 | The authors reply |
| Q94331839 | The authors reply |
| Q94353909 | The authors reply |
| Q92547617 | The ex vivo human lung: research value for translational science |
| Q34424957 | The influence of race on the development of acute lung injury in trauma patients |
| Q58858838 | The lectin-like domain of tumor necrosis factor-α increases membrane conductance in microvascular endothelial cells and peritoneal macrophages |
| Q37413838 | The pathogenetic and prognostic value of biologic markers in acute lung injury |
| Q30539168 | The phosphatase CD148 promotes airway hyperresponsiveness through SRC family kinases. |
| Q94492968 | The potential of lipid mediator networks as ocular surface therapeutics and biomarkers |
| Q51708241 | The pulmonary epithelium is an important mediator of ventilator-induced lung injury. |
| Q83567322 | The role of angiotensin-converting enzyme inhibition in endotoxin-induced lung injury in rats |
| Q46953002 | The role of protein C in sepsis |
| Q42430607 | The severity of shock is associated with impaired rates of net alveolar fluid clearance in clinical acute lung injury |
| Q34603444 | The utility of clinical predictors of acute lung injury: towards prevention and earlier recognition |
| Q91464771 | The value of kinetic glomerular filtration rate estimation on medication dosing in acute kidney injury |
| Q36096318 | Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice. |
| Q92479438 | Therapeutic Effects of Hyaluronic Acid in Bacterial Pneumonia in Ex Vivo Perfused Human Lungs |
| Q90746387 | Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E. coli pneumonia |
| Q36917444 | Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria |
| Q34184246 | Therapeutic potential of mesenchymal stem cells for severe acute lung injury |
| Q35604449 | Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome |
| Q58085562 | Therapeutic potential of mesenchymal stromal cells in the treatment of ARDS |
| Q35920405 | Therapeutic strategies for severe acute lung injury |
| Q73230537 | Therapeutic strategies to hasten the resolution of pulmonary edema |
| Q47686618 | Therapeutic value of a lung protective ventilation strategy in acute lung injury |
| Q59650729 | Thinking outside the box: Introduction |
| Q34026781 | Thirty years of critical care medicine |
| Q91637739 | Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment |
| Q44153346 | Time-dependent effect of pneumonectomy on alveolar epithelial fluid clearance in rat lungs |
| Q36641496 | Timing of Intubation and Clinical Outcomes in Adults With Acute Respiratory Distress Syndrome |
| Q112291195 | Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS |
| Q33717387 | Transforming growth factor beta1 inhibits cystic fibrosis transmembrane conductance regulator-dependent cAMP-stimulated alveolar epithelial fluid transport via a phosphatidylinositol 3-kinase-dependent mechanism |
| Q51660268 | Transforming growth factor-beta induces fibrosis in immune cell-depleted lungs. |
| Q44557683 | Transforming growth factor-beta1 decreases expression of the epithelial sodium channel alphaENaC and alveolar epithelial vectorial sodium and fluid transport via an ERK1/2-dependent mechanism |
| Q51645076 | Transforming growth factor-β1 regulates lung epithelial barrier function and fluid transport |
| Q35833981 | Transfusion-related acute lung injury: a review |
| Q35777001 | Transfusion-related acute lung injury: incidence and risk factors. |
| Q35843296 | Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury |
| Q37396389 | Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders |
| Q46260572 | Treating ARDS: new hope for a tough problem |
| Q90593642 | Treatment for severe acute respiratory distress syndrome from COVID-19 |
| Q46444097 | Treatment of acute lung injury: clinical and experimental studies |
| Q36565930 | Treatment of acute lung injury: historical perspective and potential future therapies |
| Q93219844 | Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial |
| Q46522466 | Understanding blood gas analysis. |
| Q35716122 | Update on acute lung injury and critical care medicine 2009. |
| Q33808300 | Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury |
| Q33574264 | Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection |
| Q57061340 | Variability in Pediatric Ideal Body Weight Calculation: Implications for Lung-Protective Mechanical Ventilation Strategies in Pediatric Acute Respiratory Distress Syndrome |
| Q35559405 | Vascular pedicle width in acute lung injury: correlation with intravascular pressures and ability to discriminate fluid status |
| Q34843994 | Ventilator-induced lung injury: in vivo and in vitro mechanisms |
| Q30352743 | Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic |
| Q35959840 | Visualization of Fra-1/AP-1 activation during LPS-induced inflammatory lung injury using fluorescence optical imaging |
| Q44034230 | Warm ischemia-induced alterations in oxidative and inflammatory proteins in hepatic Kupffer cells in rats |
| Q43998311 | What drives neutrophils to the alveoli in ARDS? |
| Q45044085 | Why does acute lung injury have no impact on mortality in patients with major trauma? |
| Q60153737 | Withholding and Withdrawing Life-Sustaining Therapy |
| Q36064954 | miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis |
Search more.